Does Fedratinib 100 Mg Capsule Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED IMMUNOSUPPRESSANTS/NADOFARAGENE FIRADENOVEC
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (>25 MG)
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (>21 MG)
- DUAL STRONG OR MODERATE CYP2C19 & 3A4 INHIBITORS/MAVACAMTEN
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- SLT STRONG & MODERATE CYP2C19 INHIBITORS/CILOSTAZOL (> 50MG)
- SELECTED CYP3A4 MODERATE INHIBITORS/LURASIDONE (> 80 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- SELECTED IMMUNOSUPPRESSANTS/TALIMOGENE LAHERPAREPVEC
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (> 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (> 500 MG BID)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (> 50 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- SELECTED IMMUNOSUPPRESSIVE AGENTS/LIVE VACCINES; LIVE BCG
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/EFALIZUMAB; NATALIZUMAB
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- FEDRATINIB/STRONG CYP3A4 INHIBITORS
- FEDRATINIB/STRONG CYP3A4 INDUCERS
- FEDRATINIB/MODERATE CYP3A4 INDUCERS
- FEDRATINIB/VORICONAZOLE
- ANTINEOPLASTIC SYST ENZYME INH THAT INHIBIT 3A4/CARBAMAZEPIN
- FEDRATINIB/MITAPIVAT
- CYP3A4 INHIBITORS AND SUBSTRATES/ENCORAFENIB
- MYELOSUPPRESSIVE MOD-WEAK 3A4 INH/SIROLIMUS PROTEIN-BOUND
- MYELOSUPPRESSIVE MOD-WEAK CYP3A4 INH/TACROLIMUS
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- CYP3A4 INHIBITORS AND SUBSTRATES/REPOTRECTINIB
- MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
- SELECTED MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- MODERATE CYP3A4 INHIBITORS/COLCHICINE (FOR CARDIOPROTECTION)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/RITLECITINIB
- MODERATE CYP3A4 INHIBITORS & SUBSTRATES/PEXIDARTINIB
- MODERATE CYP3A4 INHIBITORS/OMAVELOXOLONE
- FEDRATINIB/BOSENTAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- DUAL CYP3A4 & WEAK CYP2D6 INHIBITORS/ELIGLUSTAT
- MODERATE CYP3A4 INHIBITORS/PACRITINIB
- MODERATE CYP3A4 INHIBITORS/MOBOCERTINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/CLADRIBINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SIPONIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/OZANIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FINGOLIMOD
- STRONG AND MODERATE CYP3A4 INHIBITORS/FEXINIDAZOLE
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FILGOTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- SELECTED MODERATE CYP3A4 INHIBITORS/ALPRAZOLAM
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/PONESIMOD
- SELECTED IMMUNOSUPPRESSANTS/LEFLUNOMIDE; TERIFLUNOMIDE
- MODERATE CYP3A4 INHIBITORS/VOCLOSPORIN
- FEDRATINIB/IVOSIDENIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PRALSETINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/BARICITINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/INEBILIZUMAB
- MODERATE CYP3A4 INHIBITORS/SELPERCATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- MODERATE CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- MODERATE CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UPADACITINIB
- MODERATE CYP3A4 INHIBITORS/ENTRECTINIB
- MODERATE CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- MODERATE CYP3A4 INHIBITORS/VENETOCLAX
- IMMUNOSUPPRES;IMMUNOMODUL/SELECTED MULTIPLE SCLEROSIS AGENTS
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (<= 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/COBIMETINIB; OLAPARIB; SONIDEGIB
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (> 10 MG)
- MODERATE CYP3A4 INHIBITORS/ERGOT ALKALOIDS
- SELECTED MODERATE CYP3A4 INHIBITORS/PIMOZIDE
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- SELECTED MYELOSUPPRESSIVE AGENTS/CLOZAPINE
- SELECTED CYP2C19 INHIBITORS/CLOPIDOGREL
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOFACITINIB
- MODERATE CYP3A4 INHIBITORS/BOSUTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- SELECTED MYELOSUPPRESSIVE AGENTS/DEFERIPRONE
- SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
- MODERATE CYP3A4 INHIBITORS/COLCHICINE
- MODERATE CYP3A4 INHIBITORS/TOLVAPTAN
- MODERATE CYP3A4 INHIBITORS/IVABRADINE
- SELECTED MODERATE CYP3A4 INHIBITORS/EPLERENONE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- FEDRATINIB/DUAL INHIBITORS OF CYP2C19 & CYP3A4
- MODERATE CYP3A4 INHIBITORS/MACITENTAN
- MODERATE CYP3A4 INHIBITORS/FINERENONE
- MODERATE CYP3A4 INHIBITORS/CAPIVASERTIB
- SELECTED MODERATE CYP3A4 INHIBITORS/CYCLOSPORINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/ETRASIMOD
- MODERATE CYP3A4 INHIBITORS/GEPIRONE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOCILIZUMAB
- MODERATE CYP3A4 INHIBITORS/PALOVAROTENE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UBLITUXIMAB
- MODERATE CYP3A4 INHIBITORS/LAROTRECTINIB
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (<=21 MG)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SARILUMAB
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (<=25 MG)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/COVID-19 VACCINES
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/USTEKINUMAB
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- MODERATE CYP3A4 INHIBITORS/RIMEGEPANT
- MODERATE CYP3A4 INHIBITORS/AVAPRITINIB
- MODERATE CYP3A4 INHIBITORS/UBROGEPANT
- MODERATE CYP3A4 INHIBITORS/ZANUBRUTINIB
- MODERATE CYP3A4 INHIBITORS/ORAL LEFAMULIN
- SLT STRONG & MODERATE CYP2C19 INHIBITORS/CILOSTAZOL (<=50MG)
- SELECTED CYP3A4 MODERATE INHIBITORS/LURASIDONE (<= 80 MG)
- MODERATE CYP3A4 INHIBITORS/ABEMACICLIB
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
- MODERATE CYP3A4 INHIBITORS/CABERGOLINE
- SELECTED MODERATE CYP3A4 INHIBITORS/ACALABRUTINIB
- MODERATE CYP3A4 INHIBITORS/QUETIAPINE
- MODERATE CYP3A4 INHIBITORS/BROMOCRIPTINE
- MODERATE CYP3A4 INHIBITORS/BREXPIPRAZOLE
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (<= 10 MG)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (<= 50 MG)
- MODERATE CYP3A4 INHIBITORS/IBRUTINIB
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
- SELECTED MODERATE CYP2C19 INHIBITORS/CLOBAZAM
- SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
- SELECTED CYP2D6 INHIBITORS/METOPROLOL
- SELECTED MODERATE CYP3A4 INHIBITORS/SELECTED OPIOIDS
- MODERATE CYP3A4; P-GP INHIBITORS/EVEROLIMUS
- SELECTED WEAK CYP2D6 INHIBITORS/TAMOXIFEN
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (<=500 MG BID)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.